Cycloxaprid Patent Landscape Analysis

Cycloxaprid is a neonicotinoid insecticide originating from research at East China University of Science and Technology (ECUST), with commercial development associated with Shanghai Shengnong.

The retained landscape covers 127 patent families across 64 consolidated owner groups. Insecticide combination is the thickest protection layer (90 families), with formulation and delivery providing additional constraint.

Ninety-two of the 127 retained families carry a grant or national pending reading. All 127 retained families are held by China-based applicants; seventeen live families have a nominal term ending within five years. Position as at October 2026.

This 58-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.